Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Ocular Therapeutix, Inc.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Had prior bilateral treatment and completion, through a minimum of week 12, of the OTX-16-002 trial
Are informed of the nature of the study and subject is able to comply with study requirements and visit schedule for one year
Have provided written informed consent, approved by the appropriate Institutional Review Board
You may not be if
Had more than 1 replacement, per eye, during participation in the OTX-16-002 trial
Had punctal or canaliculi related adverse events during the OTX-16-002 trial which required discontinuation (e.g., canaliculitis)
Used prohibited medications during the OTX-16-002 study, or the period between OTX-16-002 and this trial (with the exception of short term medication used to treat an adverse event or rescue therapy)
Missed more than 2 visits during participation in the OTX-16-002 trial
